To recover your password please fill in your email address
Please fill in below form to create an account with us
A Phase III randomised, controlled trial of exercise during chemotherapy for patients commencing first-line treatment for ovarian cancer.
See ANZCTR for full trial details >
Trial Summary: |
The aim of this study is to determine effect of a structured exercise intervention on physical wellbeing at post-intervention and 6 and 12 months post-randomisation. |
Supported By: |
This study is a collaboration between Griffith University, the Australia New Zealand Gynaecological Oncology Group (ANZGOG) and the NHMRC Clinical Trials Centre (CTC), University of Sydney |
Eligibility: |
Patients ≥18 years, newly diagnosed with epithelial ovarian, primary peritoneal or fallopian tube cancer and scheduled for chemotherapy. |
Registration ID: |
ACTRN12614001311640 |
Participation: |
Australia |
Australian Lead Group: |
ANZGOG |
Status: |
In follow-up |
Activation Date: |
2014 |
Chairs: |
Prof Sandi Hayes |
Contact: |
echo.study@sydney.edu.au |